BARILARO, ALESSANDRO
BARILARO, ALESSANDRO
SCIENZE NEUROLOGICHE E PSICHIATRICHE (attivo dal 01/08/1980 al 31/12/2012)
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet
2019 Pasca M.; Picchioni A.; Mazzeo S.; Terenzi F.; Prestipino E.; Fratangelo R.; Repice A.M.; Carlucci G.; Massacesi L.; Barilaro A.
A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency
2017 Paganini, I.; Sestini, R.; Capone, G. L.; Putignano, A. L.; Contini, E.; Giotti, I.; Gensini, F.; Marozza, A.; Barilaro, A.; Porfirio, B.; Papi, L.
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis.
2017 M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L.
Acute cerebellar ataxia: a rare Toscana Virus (TOSV) meningoencephalitis complication
2019 Suardi L.R.; Di Lauria N.; Pozzi M.; Rogasi P.G.; Barilaro A.; Azzolini F.; Prestipino E.; Colao M.G.; Rossolini G.M.; Bartoloni A.
Anti-MAG IgM: differences in antibody tests and correlation with clinical findings
2020 Mata S.; Ambrosini S.; Saccomanno D.; Biagioli T.; Carpo M.; Amantini A.; Giannini F.; Barilaro A.; Toscani L.; Del Mastio M.; Comi G.P.; Sorbi S.
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
In corso di stampa Mariottini A, Repice AM, Barilaro A, Massacesi L
Antigen Driven T-Cell Response in CSF of Multiple Sclerosis Patients
2010 Ballerini, C; Galante, A; Biagioli, T; Repice, A; Barilaro, A; Aldinucci, A; Massacesi, L
Autoimmune epilepsy in drug resistent and in new onset refractory epilepsy
2018 Pradella, S; Paganini, M; Barilaro, A; Casagrande, S; Biagioli, T; Franciotta, D; Massacesi, L
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis
2022 Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca
Azathioprine and interferon beta1a relative efficacy on prevention of new brain lesions in relapsing remitting multiple sclerosis
2004 Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L
Azathioprine versus interferon-beta-1a s.c.: efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis
2004 Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L
Azathioprine-interferon beta 1a s.c. association in relapsing-remitting multiple sclerosis: compliance and efficacy in prevention of new brain lesions
2004 Repice, A; Barilaro, A; Parigi, A; Taiuti, B; Pellicano, G; Meucci, G; Fioretti, C; Valleriani, A; Onesti, E; Prosperini, L; Pozzilli, C; Massacesi, L
Central vein sign differentiates MS from CNS inflammatory vasculopathies.
2018 Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L.
Cerebral perfusion abnormalities in multiple sclerosis patients with markers of systemic autoimmunity
2009 Caleri, F; Repice, A; Zellini, F; Barilaro, A; De Cristofaro, MT; Pupi, A; Massacesi, L
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions
2021 Antonio Farina, Alice Mariottini, Federica Azzolini, Claudia Mechi, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study
2019 Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation
2019 Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L
Comparing human bone marrow mesenchymal stem cells isolated from MS patients with ND ones: possible impact on MS therapy and immunopathology
2009 Mazzanti, B; Aldinucci, A; Biagioli, T; Barilaro, A; Crescioli, C; Saccardi, R; Massacesi, L; Ballerini, C
Comparison of azathioprine and of beta interferon efficacy on measures of brain damage evaluated by MRI in relapsing-remitting multiple sclerosis
2016 Massacesi, L; Grammatico, M; Vuolo, L; Barilaro, A; Benedetti, MD; La Mantia, L; Milanese, C; Repice, AM; Solari, A; Tedeschi, G; Filippini, G
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis
2018 Aldinucci A, Bonechi E, Biagioli T, Repice AM, D'Elios MM, Emmi L, Emmi G, Silvestri E, Barilaro A, Ballerini C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet | 2019 | Pasca M.; Picchioni A.; Mazzeo S.; Terenzi F.; Prestipino E.; Fratangelo R.; Repice A.M.; Carlucci G.; Massacesi L.; Barilaro A. | |
| A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency | 2017 | Paganini, I.; Sestini, R.; Capone, G. L.; Putignano, A. L.; Contini, E.; Giotti, I.; Gensini, F.; Marozza, A.; Barilaro, A.; Porfirio, B.; Papi, L. | |
| Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. | 2017 | M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L. | |
| Acute cerebellar ataxia: a rare Toscana Virus (TOSV) meningoencephalitis complication | 2019 | Suardi L.R.; Di Lauria N.; Pozzi M.; Rogasi P.G.; Barilaro A.; Azzolini F.; Prestipino E.; Colao M.G.; Rossolini G.M.; Bartoloni A. | |
| Anti-MAG IgM: differences in antibody tests and correlation with clinical findings | 2020 | Mata S.; Ambrosini S.; Saccomanno D.; Biagioli T.; Carpo M.; Amantini A.; Giannini F.; Barilaro A.; Toscani L.; Del Mastio M.; Comi G.P.; Sorbi S. | |
| Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance | In corso di stampa | Mariottini A, Repice AM, Barilaro A, Massacesi L | |
| Antigen Driven T-Cell Response in CSF of Multiple Sclerosis Patients | 2010 | Ballerini, C; Galante, A; Biagioli, T; Repice, A; Barilaro, A; Aldinucci, A; Massacesi, L | |
| Autoimmune epilepsy in drug resistent and in new onset refractory epilepsy | 2018 | Pradella, S; Paganini, M; Barilaro, A; Casagrande, S; Biagioli, T; Franciotta, D; Massacesi, L | |
| Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis | 2022 | Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca | |
| Azathioprine and interferon beta1a relative efficacy on prevention of new brain lesions in relapsing remitting multiple sclerosis | 2004 | Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L | |
| Azathioprine versus interferon-beta-1a s.c.: efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis | 2004 | Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L | |
| Azathioprine-interferon beta 1a s.c. association in relapsing-remitting multiple sclerosis: compliance and efficacy in prevention of new brain lesions | 2004 | Repice, A; Barilaro, A; Parigi, A; Taiuti, B; Pellicano, G; Meucci, G; Fioretti, C; Valleriani, A; Onesti, E; Prosperini, L; Pozzilli, C; Massacesi, L | |
| Central vein sign differentiates MS from CNS inflammatory vasculopathies. | 2018 | Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L. | |
| Cerebral perfusion abnormalities in multiple sclerosis patients with markers of systemic autoimmunity | 2009 | Caleri, F; Repice, A; Zellini, F; Barilaro, A; De Cristofaro, MT; Pupi, A; Massacesi, L | |
| Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions | 2021 | Antonio Farina, Alice Mariottini, Federica Azzolini, Claudia Mechi, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi | |
| Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study | 2019 | Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM | |
| Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation | 2019 | Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L | |
| Comparing human bone marrow mesenchymal stem cells isolated from MS patients with ND ones: possible impact on MS therapy and immunopathology | 2009 | Mazzanti, B; Aldinucci, A; Biagioli, T; Barilaro, A; Crescioli, C; Saccardi, R; Massacesi, L; Ballerini, C | |
| Comparison of azathioprine and of beta interferon efficacy on measures of brain damage evaluated by MRI in relapsing-remitting multiple sclerosis | 2016 | Massacesi, L; Grammatico, M; Vuolo, L; Barilaro, A; Benedetti, MD; La Mantia, L; Milanese, C; Repice, AM; Solari, A; Tedeschi, G; Filippini, G | |
| CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis | 2018 | Aldinucci A, Bonechi E, Biagioli T, Repice AM, D'Elios MM, Emmi L, Emmi G, Silvestri E, Barilaro A, Ballerini C |